Adhera Therapeutics, Inc. Debt Instrument, Convertible, Conversion Price
Adhera Therapeutics, Inc. had Debt Instrument, Convertible, Conversion Price of $0.05 per share as of 2021-11-30, per its 10-K filed 2022-04-15.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2022-04-15
- 2021-11-30: Debt Instrument, Convertible, Conversion Price $0.05.
- 2020-05-05: Debt Instrument, Convertible, Conversion Price $0.50.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2021-11-30 | $0.05 10-K · filed 2022-04-15 |
| 2020-05-05 | $0.50 10-K · filed 2021-04-07 |